A watch-and-wait strategy or local excision in complete clinical responders after radiation for early-stage rectal cancer

Affiliations

¹ Department of Radiotherapy, Military Institute of Medicine, Warsaw, Poland; Department of Radiotherapy, Regional Oncology Center, Czestochowa, Poland.
² Department of Radiotherapy I, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: krzysztof.bujko@pib-nio.pl.

Free article

Comment

Joanna Socha et al. Lancet Healthy Longev. 2022 Dec.

Free article

. 2022 Dec;3(12):e807-e808.

doi: 10.1016/S2666-7568(22)00240-9. Epub 2022 Nov 17.

¹ Department of Radiotherapy, Military Institute of Medicine, Warsaw, Poland; Department of Radiotherapy, Regional Oncology Center, Czestochowa, Poland.
² Department of Radiotherapy I, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: krzysztof.bujko@pib-nio.pl.

No abstract available

Conflict of interest statement

We declare no competing interests.

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision.
Gilbert A, Homer V, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton M, Khan J, Robinson J, Steward M, Cunningham C, Kaur M, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D, Bach SP; TREC collaborators. Gilbert A, et al. Lancet Healthy Longev. 2022 Dec;3(12):e825-e838. doi: 10.1016/S2666-7568(22)00239-2. Epub 2022 Nov 17. Lancet Healthy Longev. 2022. PMID: 36403589 Free PMC article. Clinical Trial.